Skip to main content
. 2020 Dec 18;4(6):pkaa082. doi: 10.1093/jncics/pkaa082

Figure 3.

Figure 3.

Patients whose p16INK4a expression levels are increased by chemotherapy are not restricted to any 1 treatment. Distribution of patients whose p16INK4a levels increased above assay precision is similar among chemotherapy regimens commonly used to treat early stage breast cancer patients.